Cargando…
Antimicrobial-resistant Shigella: where do we go next?
Shigella spp. that are resistant to almost all antimicrobial classes are increasing in prevalence and becoming globally dominant. The situation is critical and highlights a trend that is mirrored by other enteric bacterial pathogens. New interventions to prevent and treat these infections are essent...
Autores principales: | Baker, Stephen, Scott, Timothy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184058/ https://www.ncbi.nlm.nih.gov/pubmed/37188805 http://dx.doi.org/10.1038/s41579-023-00906-1 |
Ejemplares similares
-
The impact of ICCPR's Global Audit of Cardiac Rehabilitation: where are we now and where do we need to go?
por: Turk-Adawi, Karam, et al.
Publicado: (2023) -
Exposure to artificial light at night and risk of cancer: where do we go from here?
por: Jones, Rena R.
Publicado: (2021) -
Lung cancer and Covid-19: lessons learnt from the pandemic and where do we go from here?
por: Maxwell, Susanne Sarah, et al.
Publicado: (2022) -
Point-of-care screening for atrial fibrillation: Where are we, and where do we go next?
por: Ashburner, Jeffrey M., et al.
Publicado: (2021) -
Public communication about public health where we really need to go
por: Ranney, Megan L., et al.
Publicado: (2022)